Delilah Todd

Sep 29, 2024 | mondaq.com | David A. Sakowitz |Ben Smolij |Jacob Tabman |Delilah Todd

On August 26, 2024, the Securities and Exchange Commission (SEC) issued an order approving amendments to Nasdaq rules related to phase-in periods (the Phase-In Amendments) and cure periods (the Cure Period Amendments, and, together with the Phase-In Amendments, the Amendments). The Amendments are consistent with the NYSE's previously approved amendments to its corporate governance requirements and were described as "reasonable" by the SEC.